Nanoviricides Inc is a development stage nano-biopharmaceutical company. Its business activities are to discover, develop and commercialize therapeutics to take care of patients suffering from life-threatening viral infections.
| Website: | www.nanoviricides.com |
| Email: | info@nanoviricides.com |
| Main Phone: | +1 203 937-6137 |
| Address: | 1 Controls Drive |
| State: | CT |
| City / Town: | Shelton |
| Country: | USA |
| Postal Code: | 6484 |
| Exchange: | AMX |
| Employees: | 6 |
| NAICS: | Pharmaceutical P |
| Last Price 1.27 | Change $ 0. | Change % 0.00 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 1.25 | High 1.29 | Low 1.25 | Prev Close 1.27 |
| Last Trade | Volume 24,442 | 52 Wk Hi 1.71 | 52 Wk Low 1.03 |
| Market Cap 80.1 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 63,072,000.00 | EPS (TTM) -0.16 | PE Ratio N/A | Exchange NYSE American |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 24 |
| Number of Buys | 0 | 20 |
| Number of Sells | 0 | 4 |
| Net Activity | 0 | 206098 |
| Last 10 Buys | Shares |
|---|---|
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 7.21 | 7.21 | 7.21 | 7.21 |
| Low Target Price Estimate | 7.21 | 7.21 | 7.21 | 7.21 |
| Mean Target Price Estimate | 7.21 | 7.21 | 7.21 | 7.21 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 09/16/14 | 09/16/14 | 09/16/14 | 09/16/14 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-18 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 58 | 2016-05-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-02 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2016-04-14 |
| POS AM | Post-effective amendment to an S-Type filing | 2 | 2016-04-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-02-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-02-16 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 108 | 2016-02-09 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
